← Back to Search

Prism Adaptation Therapy for Stroke-Related Perceptual Disorders

N/A

Waitlist Available

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Will be or has been admitted to the Craig H. Neilson Rehabilitation Hospital for rehabilitation or is able to come to the Craig H. Neilson Rehabilitation Hospital for prism adaptation therapy sessions

Able to sit in a wheelchair or other chair for 1 hour

Timeline

Screening 3 weeks

Treatment Varies

Follow Up post-intervention immediately after prism adaptation therapy

Awards & highlights

Study Summary

This trial will test whether neglect can be improved following Prism Adaptation Training, and if so, what kind of brain damage predicts this improvement.

Who is the study for?

This trial is for adults aged 18-90 who've had a right hemisphere stroke within the last month and are suspected of having spatial neglect. They must be able to consent, sit for an hour, point straight ahead, hold a pen with their right hand, and undergo MRI scans. They should not have other conditions affecting testing or training ability.Check my eligibility

What is being tested?

The study is looking at how effective Prism Adaptation Therapy is in treating spatial neglect caused by right hemisphere strokes. It aims to identify if brain damage patterns can predict the type of neglect and response to this therapy.See study design

What are the potential side effects?

Since this trial involves behavioral therapy rather than medication, traditional side effects are not expected; however, participants may experience fatigue or discomfort from sitting during sessions or any standard risks associated with undergoing MRI scans.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I will be or have been admitted to Craig H. Neilson Rehabilitation Hospital for therapy.

Select...

I can sit in a chair for at least an hour.

Select...

I had a stroke affecting the right side of my brain within the last month.

Select...

I am between 18 and 90 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ post-intervention immediately after prism adaptation therapy

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~post-intervention immediately after prism adaptation therapy

This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention immediately after prism adaptation therapy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Catherine Bergego Scale

Secondary outcome measures

Behavioral Attention Test conventional subtests

Trial Design

1Treatment groups

Experimental Treatment

Group I: Prism Adaptation TherapyExperimental Treatment1 Intervention

10 sessions (60 trials each) 1x/day of Prism Adaptation Therapy

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor

1,098 Previous Clinical Trials

1,778,618 Total Patients Enrolled

Media Library

Prism Adaptation Therapy Clinical Trial Eligibility Overview. Trial Name: NCT04966000 — N/A

Perceptual Disorders Research Study Groups: Prism Adaptation Therapy

Perceptual Disorders Clinical Trial 2023: Prism Adaptation Therapy Highlights & Side Effects. Trial Name: NCT04966000 — N/A

Prism Adaptation Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04966000 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any new volunteers being welcomed into this research endeavor?

"The clinical trial hosted on clinicialtrials.gov is not currently open to recruitment, as it was last updated on May 16th 2022. Although this particular study has closed its doors for the time being, there are still over a thousand other medical trials actively seeking participants at present."

Answered by AI

To what extent is enrollment in this research project open to the public?

"This research is seeking a cohort of 12 individuals, aged 18 to 90 years old and having sustained an incapacitating stroke. In addition to this medical criterion, potential participants must be able to provide their own consent for the trial; accommodate 10-12 days in rehabilitation or return for ten therapy sessions at Craig H. Neilson Rehabilitation Hospital; remain seated in a wheelchair or other chair for 1 hour; demonstrate unilateral spatial neglect through pointing straight ahead and holding a pen with right hand."

Answered by AI

Does the trial accept participants over four decades of age?

"This study is open to individuals aged 18-90. There are 40 trials available for minors and 1024 clinical studies accessible to those older than 65 years old."

Answered by AI

Recent research and studies

Neuropsychological RehabilitationJournal

Frontal Lesions Predict Response to Prism Adaptation Treatment in Spatial Neglect: A Randomised Controlled Study

Goedert, Kelly M., Peii Chen, Anne L. Foundas, and A. M. Barrett. 2018. “Frontal Lesions Predict Response to Prism Adaptation Treatment in Spatial Neglect: A Randomised Controlled Study”. Neuropsychological Rehabilitation. Informa UK Limited. doi:10.1080/09602011.2018.1448287.

Neurorehabilitation and Neural RepairJournal

Presence of Motor-intentional Aiming Deficit Predicts Functional Improvement of Spatial Neglect with Prism Adaptation

Goedert, Kelly M., Peii Chen, Raymond C. Boston, Anne L. Foundas, and A. M. Barrett. 2013. “Presence of Motor-intentional Aiming Deficit Predicts Functional Improvement of Spatial Neglect with Prism Adaptation”. Neurorehabilitation and Neural Repair. SAGE Publications. doi:10.1177/1545968313516872.

clinicaltrials.govStudy

Neurobiomarker for Prism Adaptation Treatment Response

Lorie Richards 2024. "Neurobiomarker for Prism Adaptation Treatment Response". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04966000.